Venous Sclerosing Agents Under Renewed Safety Scrutiny: ANSM Highlights Persistent Cardiovascular Risks

Recent pharmacovigilance updates from the French National Agency for the Safety of Medicines and Health Products (ANSM) have renewed attention to the safety profile...

Hemodynamic Phlebology and the CHIVA Method: An Educational Session with Claude Franceschi

The Italian and International Academy of Hemodynamic Phlebology is pleased to announce an upcoming educational event dedicated to hemodynamic phlebology and the C.H.I.V.A. method. This...

Pseudo-CHIVA: When Ablation Is Called CHIVA

A Conceptual Clarification and Boundary Framework in Venous Surgery Dr. Qiang Zhang Looking forward, the evolution of venous surgery should not be viewed as a conflict...

Hong Kong Collaboration Highlights a Shift Toward System-Based Development in Asian Phlebology

Recent developments in Hong Kong suggest that venous medicine in Asia is entering a new phase of system-oriented collaboration. A strategic cooperation agreement signed...

Building a Common Language for Hemodynamic Venous Care: The Global CHIVA Program Enters Its Tier 1 Pilot

December 8, 2025 — United StatesAs interest in hemodynamic-guided approaches to venous disease continues to rise, one challenge has remained consistent across countries: the...